Report Highlights
The global anesthesia and respiratory devices market should reach $36.2 billion by 2022 and more than $51 billion by 2027, with a compound annual growth rate (CAGR) of 7.1% during the forecast period of 2022-2027.
Report Includes
- 56 data tables and 17 additional tables
- An up-to-date review and analysis of the global markets for anesthesia and respiratory devices
- Analyses of the global market trends, with historic sales data from 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current and future potential in the market for anesthesia and respiratory devices, and areas to forecast this market into various segments and sub-segments
- Estimation of the actual market size for anesthesia and respiratory devices, market growth forecast, and corresponding market share analysis by product type and geographic region
- Country specific data and analysis for the U.S., Canada, Mexico, Japan, China, India, U.K., France, Germany, Italy, Spain, and other prominent economies
- In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
- Key merger and acquisition deals, partnerships, collaborations and joint ventures as well as other strategic alliances in the global market for anesthesia and respiratory devices
- Market share analysis of the key market participants, along with their research priorities, product portfolios, and competitive landscape
- Company profiles of major players within the industry, including Abbott, B. Braun, Becton Dickson, Medtronic and Koninklijke Philips.
Report Scope
Market reports are the ideal guide for anyone wishing to understand a specific market better in terms of revenues, technology innovations, distributors, and competitors. This report provides both an overview and country-level information for various categories and distribution shares, and explores the competitive landscape of the market.
Comprehensive data related to the market revenue, company share, and distribution share are included.
This report includes corporate-level profiles of key companies in the anesthesia and respiratory devices market that operate in the United States and other key countries, including a brief overview of each company, its business activities, and its hold or presence in the respective market. The selection of the companies is based on their operational presence and sales performance.
A list of products under development by key companies in which these products are being clinically investigated is also included.
The market has been segmented based on device type and geographic area. By type, the market has been segmented into anesthesia devices and consumables and respiratory devices and disposables. By geography, the market has been segregated as North America including the United States (U.S.), Canada, and Mexico; Europe including Germany, the United Kingdom (U.K.), France, and Italy; Asia-Pacific including China, India, Japan, Australia, New Zealand, South Korea, and South Africa; the Middle East, including the United Arab Emirates; and South America, including Brazil and Argentina.
This market research report includes anesthesia and respiratory devices segregated as below in categories based on their nature and usage.
Airway and anesthesia devices:
• Airway management devices.
• Anesthesia circuits.
• Anesthesia masks.
• Breathing filters.
• Laryngoscope blades.
• Laryngoscope handles.
Anesthesia machines:
• Portable anesthesia delivery machines.
• Stand-alone anesthesia delivery machines.
• Anesthesia workstations.
Pain management devices.
Regional anesthesia disposables:
• Epidural anesthesia disposables.
• Peripheral anesthesia disposables.
• Spinal anesthesia disposables.
Respiratory devices:
• Humidifiers.
• Nebulizers.
• Oxygen concentrators.
• Oxygen conservers.
• Positive airway pressure devices.
• Reusable resuscitators.
• Ventilators
Respiratory disposables:
• Aerosol masks.
• Cardio-pulmonary resuscitation (CPR) barriers.
• Nasal cannula.
• Oxygen masks.
• Patient interface.
• Resuscitators.
Respiratory measurement devices:
• Capnographs.
• Spirometers.
• Pulse oximeter systems.
Sleep apnea diagnostic systems:
• Fixed polysomnography systems.
• Portable polysomnography systems.
Report Synopsis
| Report Metrics | Details | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||
| Forecast period considered | 2022–2027 | ||||||||||||||
| Base year market size | $33.8 billion | ||||||||||||||
| Market size forecast | $51.0 billion | ||||||||||||||
| Growth rate | CAGR of 7.1% from 2022 to 2027 | ||||||||||||||
| Units considered | $ Millions | ||||||||||||||
| Segments covered | Type, Region | ||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||||
| Countries covered | United States (U.S.). , Mexico., Canada., United Kingdom (U.K.)., France., Russia., Germany., Italy., Others., China., India., Japan., South Korea., Others., South America., Middle East and Africa. | ||||||||||||||
| Key Market Drivers |
|
||||||||||||||
| Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Siemens: 360° Company Analysis (IFT322A)
- Thermo Fisher Scientific Inc.: 360° Company Analysis (HLC309A)
- Needle-Free Devices: Technologies and Global Markets (HLC178C)
- Koninklijke Philips N.V.: 360° Company Analysis (HLC308A)
- Global High Purity Quartz Market (CHM191A)
Related Reports
Global Implantable Remote Patient Monitoring Devices Market
The global market for implantable remote patient monitoring (IRPM) devices was valued at $6.5 billion in 2023. The market is expected to grow from $7.6 billion in 2024 to $20.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% from 2024 to 2029.
Intravenous (IV) Therapy and Vein Access: Global Markets
The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Global Injectable Drug Delivery Devices Market
The global market for injectable drug delivery device is estimated to increase from $216.5 billion in 2024 to reach $317.2 billion by 2029, at a compound annual growth rate (CAGR) of 7.9% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from $810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Thermo Fisher Scientific Inc.: 360° Company Analysis
This report provides a comprehensive analysis of Thermo Fisher Scientific Inc., covering key details such as key milestones/history, product offerings, technologies, major applications and end-user industries it serves.
Needle-Free Devices: Technologies and Global Markets
The global market for needle-free devices was valued at $15.5 billion in 2024 and is estimated to increase from $17.0 billion in 2025 to reach $27.7 billion by 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 through 2030.
Koninklijke Philips N.V.: 360° Company Analysis
The report discusses a 360° analysis of Koninklijke Philips N.V. It covers various aspects of Koninklijke Philips N.V., including products, business segments, history, distributors, and financial and strategic development.
Global Thyroid Gland Disorders: Diagnostics and Treatment Market
The global market for diagnostics and treatment of thyroid gland disorders was valued at $15.5 billion in 2024 and is estimated to increase from $16.3 billion in 2025 to reach $21.0 billion by 2030, at a compound annual growth rate (CAGR) of 5.2% from 2025 through 2030.
Global Outpatient Clinics Market
The global outpatient clinics market is expected to grow from $4.4 trillion in 2024 and is projected to reach $6.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Next-Generation Advanced Batteries: Global Markets
The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Report Highlights
The global market for anesthesia and respiratory devices will grow from nearly $21.1 billion in 2017 to nearly $26.7 billion by 2022 with a compound annual growth rate (CAGR) of 4.8% for the period of 2017-2022.
Report Includes
- 81 tables
- Country specific data and analysis for United States, Canada, Mexico, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Italy, and Russia
- Characterization and quantification of the market potential for the anesthesia and respiratory devices market by product type and region, along with subsegments
- A look at the regulatory environment, which has been a driving force in the drug development market
- Company profiles of major players in the market including, Ambu A/S, Fisher & Paykel Healthcare, Invacare Corp, Medtronic, Philips Respironics and Teleflex
Report Highlights
The global market for anesthetic and respiratory devices reached nearly $13.1 billion in 2014. The market is expected to reach nearly $24.2 billion by 2020 from $14.4 billion in 2015, increasing at a compound annual growth rate (CAGR) of 10.9% from 2015 to 2020.
Report Includes
- An overview of the global markets for anesthesia and respiratory devices in terms of growth, size and opportunities not only in regard to different products, but also geographically.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- Discussion on key market participants, extensive product segments, technologies, trends and market dynamics, competitive intelligence, as well as geographic trends.
- Coverage of various submarkets with respect to growth drivers and inhibitors of the anesthesia and respiratory devices market.
- A look at the growth trajectory of the market in regards to increasing demand from the emerging economies, particularly China and India as they have a large number of patient populations and increasing medical tourism.
- The latest concerning alliances, joint ventures, mergers and acquisitions, new product developments, and research and development.
- Profiles of major players and analysis of their core competencies and strategies in the anesthesia and respiratory devices market.
Report Highlights
The global market for anesthetic and respiratory devices reached $11.1 billion in 2012. This market is expected to grow to $12.4 billion in 2013 and $19.6 billion in 2018 with a compound annual growth rate (CAGR) of 9.5% for the five-year period, 2013 to 2018.
Report Includes
- An overview of the global market for anesthesia and respiratory devices.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Discussion on key market participants, extensive product segments, technologies, trends and market dynamics, competitive intelligence, as well as geographic trends.
- A look at the growth trajectory of the market in regards to increasing demand from the emerging economies, particularly China and India as they have a large number of patient populations and increasing medical tourism.
- Comprehensive profiles of leading companies.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More